Granted Patent
B2
US 8,193,173 · App. 11/628,841 · Granted Jun 5, 2012
Liver function ameliorant
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention relates to a liver function ameliorant containing orniplabin as an active ingredient thereof.
Claims (4)
1. A method for improving liver function comprising:
administering a therapeutically-effective amount of purified orniplabin (SMTP-7) to a patient in need thereof, wherein said patient suffers from hepatitis.
2. The method according to claim 1 , wherein orniplabin (SMTP-7) is administered in a dosage of 0.01 to 100 mg/kg of body weight per day.
3. The method according to claim 2 , wherein said dosage is administered either once per day or divided into several administrations.
Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jan 30, 2024
From: BIOGEN MA INC.
To: JI XING PHARMACEUTICALS HONG KONG LIMITED
Reel/Frame 066379/0891 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Sep 20, 2021
From: TMS CO., LTD.
To: BIOGEN MA INC.
Reel/Frame 057534/0699 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Nov 20, 2015
From: TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY TLO CO., LTD.
To: TMS CO., LTD.
Reel/Frame 037100/0639 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Dec 8, 2006
From: HASUMI, KEIJI; MAEDA, FUMIHIKO; MITSUMORI, KUNITOSHI
To: TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY TLO CO., LTD.
Reel/Frame 018699/0811 →
Continuity (1)